9 October 2018
You can vote for Willemijn here.
You can vote for Judith here.
More information and other Radboudumc nominees click here (only in Dutch).
In the annual VIVA400 list Willemijn Hobo, theme Cancer development and immune defense, and Judith van den Brule, theme Vascular damage, are nominated.
Willemijn Hobo and Judith van den Brule have the chance to be awarded in the category Knappe Koppen. Please vote before 6 November. The award ceremony is 15 November.You can vote for Willemijn here.
You can vote for Judith here.
More information and other Radboudumc nominees click here (only in Dutch).
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read moreA single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read moreDutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read moreEuropean grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more